LSB

LakeShore Biopharma
LSB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

LSB was delisted on the 19th of September, 2025.

Back to rankings

12 hedge funds and large institutions have $8.93M invested in LakeShore Biopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$194K
2
+$9.88K
3
+$177

Top Sellers

1
-$90.7K
2
-$44.4K
3
-$40.9K
4
XT
XTX Topco
Cayman Islands
-$31.1K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$21.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.63M
2
$2.16M
3
$1.29M
4
$932K
5
$601K
6
$286K
7
$10.9K
8
$9.88K
9
$5K
10
$2.06K
11
$399
12
$177
13
–
14
–
15
–
16
–
17
–
18
–